Navigation Links
Solos Endoscopy, Inc. Receives Purchase Order from One of the Major Healthcare Systems in Missouri
Date:9/10/2009

BOSTON, Sept. 10 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received a purchase order for the MammoView(TM) line of surgical endoscopy instruments from the University of Missouri Health System, which boasts one of the most comprehensive health-care networks in Missouri. They have five hospitals and numerous clinics; all staffed by University Physicians, offering the finest primary, secondary and tertiary health-care services. The University of Missouri also provides education for future health-care providers and participates in important research. Solos Endoscopy's Mammo View (TM) system employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.

Through exceptional clinical service, the University of Missouri Health System supports the education and research missions of the University of Missouri. The University of Missouri provides numerous services such as a five Level 1 Trauma Centers, Ambulatory care, a Children's Hospital. The Ellis Fischel Cancer Center is a member of University of Missouri Health System. Each year, they serve thousands of people across Missouri through their comprehensive cancer prevention, detection and treatment services.

"We are pleased to be a supplier to one of the top health care systems in the State of Missouri. The healthcare services they provide to their patients are of the highest quality and we look forward to a long relationship with the University of Missouri Health System," stated Bob Segersten, President of Solos Endoscopy, Inc.

For more information on the University of Missouri Health System, please visit: http://www.muhealth.org/

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

www.SolosEndoscopy.com


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com
2. Solos Endoscopy, Inc.s Mammo View(TM) System Now Used in Womens Hospital of Baton Rouge, LA
3. Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year
4. Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic
5. Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on Pinksheets.com
6. Solos Endoscopy, Inc.s MammoView(TM) Featured in December Issue of Surgical Products Magazine
7. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine
8. Solos Endoscopy, Inc. Receives Purchase Order from Major Connecticut Hospital for the MammoView(TM)
9. Solos Endoscopy, Inc. Successfully Completes FDA Inspection
10. Solos Endoscopy, Inc. Receives Purchase Order from Leading San Diego Healthcare Provider
11. Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into ... claim in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th ... According to the study, medical payments per claim in California decreased 4 percent in ...
(Date:12/8/2016)... Rock, AR (PRWEB) , ... December 08, 2016 ... ... providing insurance and financial planning services from offices headquartered in Little Rock, has ... Food Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an insurance ... in and around the Cape Coral area, is embarking on a charity drive with ... Southwest Florida. , The Harry Chapin Food Bank of Southwest Florida works to provide ...
(Date:12/7/2016)... KING OF PRUSSIA, PA (PRWEB) , ... December 07, 2016 , ... ... of clinical trials with the announcement that it is one of the early adopters ... EU-U.S. Privacy Shield Framework is designed to provide companies on both sides of the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to ... researcher at the Icahn School of Medicine at Mount Sinai has found. The ... when young children are exposed to secondhand marijuana smoke, measurable amounts of primary ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , 8 de dezembro de 2016  A Mederi Therapeutics Inc ... Stretta, um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and broadcast ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... Dec. 8, 2016 Bodycad announced it ... improving the accuracy, reproducibility and speed for 3D ... and small bone orthopaedic applications. These patents are ... personalized orthopaedic restorations based on each patient,s distinct ... the company harnesses the world,s first suite of ...
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
Breaking Medicine Technology: